Significant elevations of serum amylase caused by macroamylase : case reports and detection possibilities
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F23%3A00083844" target="_blank" >RIV/00023001:_____/23:00083844 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00216208:11120/23:43925256
Výsledek na webu
<a href="https://onlinelibrary.wiley.com/doi/epdf/10.1002/jcla.24859" target="_blank" >https://onlinelibrary.wiley.com/doi/epdf/10.1002/jcla.24859</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1002/jcla.24859" target="_blank" >10.1002/jcla.24859</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Significant elevations of serum amylase caused by macroamylase : case reports and detection possibilities
Popis výsledku v původním jazyce
BackgroundThe presence of isolated elevated serum amylase levels can be caused by high molecular mass complexes. We describe 13 cases of hyperamylasemia detected in adult patients without clinical symptoms of a pancreatic disorder. Five of them were thoroughly examined using different tools for the detection of macrocomplexes. MethodsWe performed both screening and more advanced methods of macroamylase detection, including polyethylene glycol precipitation, sample storage at 4 degrees C and separation by gel filtration. ResultsThe presence of macroamylase in the suspected samples was confirmed by the methods described, except for the sample storage at 4 degrees C. In this method, the enzyme activity did not decrease. The polyethylene glycol precipitation activity (% PPA) averaged 89.1% for amylase, whereas the control samples averaged 30.7%. Gel filtration chromatography confirmed an IgA macroamylase peak in three samples and an IgG macroamylase peak in two samples. ConclusionThe presence of macroamylase should be suspected whenever the clinical history and condition of the patient do not match the measured enzyme value to avoid diagnostic errors and unnecessary invasive examinations. The presence of macrocomplexes is considered a benign process that may occur in apparently healthy individuals. Cooperation between clinicians and laboratory staff is necessary.
Název v anglickém jazyce
Significant elevations of serum amylase caused by macroamylase : case reports and detection possibilities
Popis výsledku anglicky
BackgroundThe presence of isolated elevated serum amylase levels can be caused by high molecular mass complexes. We describe 13 cases of hyperamylasemia detected in adult patients without clinical symptoms of a pancreatic disorder. Five of them were thoroughly examined using different tools for the detection of macrocomplexes. MethodsWe performed both screening and more advanced methods of macroamylase detection, including polyethylene glycol precipitation, sample storage at 4 degrees C and separation by gel filtration. ResultsThe presence of macroamylase in the suspected samples was confirmed by the methods described, except for the sample storage at 4 degrees C. In this method, the enzyme activity did not decrease. The polyethylene glycol precipitation activity (% PPA) averaged 89.1% for amylase, whereas the control samples averaged 30.7%. Gel filtration chromatography confirmed an IgA macroamylase peak in three samples and an IgG macroamylase peak in two samples. ConclusionThe presence of macroamylase should be suspected whenever the clinical history and condition of the patient do not match the measured enzyme value to avoid diagnostic errors and unnecessary invasive examinations. The presence of macrocomplexes is considered a benign process that may occur in apparently healthy individuals. Cooperation between clinicians and laboratory staff is necessary.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
10608 - Biochemistry and molecular biology
Návaznosti výsledku
Projekt
—
Návaznosti
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Ostatní
Rok uplatnění
2023
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Journal of clinical laboratory analysis
ISSN
0887-8013
e-ISSN
1098-2825
Svazek periodika
37
Číslo periodika v rámci svazku
5
Stát vydavatele periodika
US - Spojené státy americké
Počet stran výsledku
8
Strana od-do
"art. no. e24859"
Kód UT WoS článku
000950546300001
EID výsledku v databázi Scopus
2-s2.0-85150656807